GE

GSK’s Hart-Scott-Rodino waiting period expires for HGS tender offer

Monday, June 4, 2012 10:55 AM

GlaxoSmithKline’s waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended, expired as of June 1, 2012, giving GSK clearance to acquire all outstanding shares of Human Genome Sciences.

More... »

Two GSK melanoma drugs garner top results

Monday, June 4, 2012 10:21 AM

GlaxoSmithKline released results from two of its phase III melanoma studies: one evaluating single agent therapy with the targeted anti-cancer agents, dabrafenib and trametinib, in patients with BRAF V600 mutation positive metastatic melanoma; and one evaluating trametinib alone.

More... »

Specialty CRO Agility Clinical is formed

Thursday, May 31, 2012 02:36 PM

David F. Hale, chairman and CEO of Hale BioPharma Ventures, has founded a new CRO, Agility Clinical, in Carlsbad, Calif.

More... »

Zyngenia appoints Frank Hsu as chief medical officer

Thursday, May 31, 2012 02:10 PM

Zyngenia, a Gaithersburg, Md.-based biopharmaceutical company developing next-generation multi-specific antibody-based drugs, has appointed Frank Hsu, M.D., as chief medical officer and a member of its executive team.

More... »

Akesis names John L. Capicchioni as new president

Thursday, May 31, 2012 12:34 PM

Akesis, a Lake Wylie, S.C.-based contract research firm specializing in phase II-IV clinical dermatology services and regulatory affairs consulting, has appointed John L. Capicchioni as its new president.

More... »

Report: Orphan drug market on the rise

Thursday, May 24, 2012 09:00 AM

GBI Research, a pharmaceutical market expert, has released its report "Orphan Disease Therapeutics Market to 2018: Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation,” which provides insights into the orphan disease therapeutics market until 2018.

More... »

Wellcome Trust awards Phagenesis $1.5 million for dysphagia treatment

Tuesday, May 22, 2012 10:02 AM

Phagenesis, a U.K. company focused on dysphagia (the inability to swallow), has been awarded $1.5 million from the Wellcome Trust to extend the scope of its dysphagia treatment device, from hospitals into the community.

More... »

GE Healthcare and Karolinska University to advance cell therapy

Tuesday, May 22, 2012 09:38 AM

Karolinska University Hospital Sweden, one of Europe's largest teaching hospitals, and GE Healthcare Life Sciences have formed a research collaboration to drive advances in technologies and workflows for use in the rapidly emerging field of cell therapy.

More... »

Icon makes senior appointments

Monday, May 21, 2012 11:52 AM

Icon, a global provider of outsourced development services, has appointed Dr. Susan Anton as director of epidemiology and risk management practice, Icon late phase & outcomes research, and Dr. Pui Leung as senior clinical research physician, Icon Development Solutions.

More... »

Applied Clinical Intelligence launches iCommittees

Thursday, May 17, 2012 11:45 AM

Applied Clinical Intelligence (ACI), a CRO based in Bala Cynwyd, Penn., has launched iCommittees, a comprehensive business solution for the use of data monitoring committees (DMCs) and endpoint adjudication committees (EACs) in clinical research trials.

More... »